NCT06876298View on ClinicalTrials.gov

Role of Uromodulin in Management of Multiple Myloma

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 25, 2025

Primary Completion Date

March 25, 2027

Study Completion Date

March 25, 2027

Conditions
Multiple Myloma
Interventions
DIAGNOSTIC_TEST

- Serum Uromodulin level quantitative test by ELISA technique at day 0, day 21 of 1st cycle and at the end of 2nd cycle of bortezomib based protocol of chemotherapy.

\- Serum Uromodulin level quantitative test by ELISA technique at day 0, day 21 of 1st cycle and at the end of 2nd cycle of bortezomib based protocol of chemotherapy.

Trial Locations (1)

71525

Assiut University, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT06876298 - Role of Uromodulin in Management of Multiple Myloma | Biotech Hunter | Biotech Hunter